Programmable chemistry unlocks drugs only in target cells, aiming to cut side effects
Scientists have developed a method of programmable chemistry that allows drugs to activate only within specific target cells, reducing harm to healthy tissues. This advancement aims to improve treatment precision by limiting drug effects to diseased cells. The approach could significantly decrease side effects and enhance patient outcomes in therapies like chemotherapy.
Scientists have developed a method to make drugs only activate inside specific target cells, such as cancer cells.
This could significantly reduce harmful side effects by preventing drugs from affecting healthy cells.
It offers a promising, precise approach to medicine that prioritizes patient safety and effective treatment.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.